Explore how generic drugs disrupt brand manufacturers' revenue, causing the 'patent cliff.' Learn about pricing dynamics, anti-competitive strategies, and the future of pharmaceutical economics.
Details
Explore the significant cost differences between brand biologics and biosimilars. Learn how biosimilars offer up to 56% savings, the real-world impact of the Humira case, and actionable steps for patients to reduce medication costs safely.
Details
Compare Canada's negotiated generic drug system with the USA's market-driven approach. Discover why prices differ, how shortages are handled, and what this means for patient access and costs.
Details
Explore why generic drug prices are often lower in the US than in Europe, despite higher overall healthcare costs, and how market structures drive this paradox.
Details